Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 150 of 268 entries
View as:

Effects of the Sangvia Blood Collection System on Postoperative Infections in Orthopedic Patients

Phase: N/A Priority: Normal
NCT ID: NCT01725724 Org: User:
Start: 12/31/09 End: 12/31/12 Due: 12/31/13

NADream: Effects of Nicotinamide Adenine Dinucleotide Supplementation on Sleep Quality in Healthy Individuals

Phase: N/A Priority: Normal
NCT ID: NCT06971224 Org: User:
Start: 05/13/25 End: 06/01/26 Due: 06/01/27

Sternal Intraosseous Transfusion of Autologous Whole Blood: A Comparison of Flow Rates and Degree of Hemolysis

Phase: N/A Priority: Normal
NCT ID: NCT02924792 Org: User:
Start: 11/30/16 End: 12/05/17 Due: 12/05/18

Infusion Related Reactions in Patients Receiving Infliximab

Phase: N/A Priority: Normal
NCT ID: NCT02332460 Org: User:
Start: 02/28/15 End: 01/31/25 Due: 01/31/26

Economic and Clinical Evaluation of Enhanced Recovery in Colorectal Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01610726 Org: User:
Start: 02/29/12 End: 12/31/16 Due: 12/31/17

Bortezomib and Temozolomide in Recurrent Grade-4 Glioma Unmethylated MGMT Promoter (BORTEM-17)

Phase: N/A Priority: Normal
NCT ID: NCT03643549 Org: User:
Start: 08/30/18 End: 12/31/25 Due: 12/31/26

Penicillin Allergy Delabeling Project

Phase: N/A Priority: Normal
NCT ID: NCT05090527 Org: User:
Start: 07/28/21 End: 05/01/23 Due: 05/01/24

A Randomized Controlled Trial of Nicotinamide Riboside Supplementation in Early Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT03568968 Org: User:
Start: 05/06/20 End: 08/30/25 Due: 08/30/26

Tissue Characterisation by Endoscopic GI-elastography

Phase: N/A Priority: Normal
NCT ID: NCT01360411 Org: User:
Start: 01/31/07 End: 07/31/12 Due: 07/31/13

Cold Stored Whole Blood in Cardiothoracic Surgery

Phase: N/A Priority: Normal
NCT ID: NCT04988620 Org: User:
Start: 06/04/21 End: 12/31/25 Due: 12/31/26

Hand Therapy or Not Following Collagenase Treatment for Dupuytren's Contracture?

Phase: N/A Priority: Normal
NCT ID: NCT03580213 Org: User:
Start: 04/05/18 End: 05/03/23 Due: 05/03/24

Switching From Insulin to Sulfonylurea in Diabetes Associated With Variants in MODY Genes

Phase: N/A Priority: Normal
NCT ID: NCT04239586 Org: User:
Start: 04/18/17 End: 04/30/22 Due: 04/30/23

Use of Blood and Plasma in Norwegian Physician-staffed Helicopter Emergency Medical System

Phase: N/A Priority: Normal
NCT ID: NCT02784951 Org: User:
Start: 01/01/16 End: 12/31/20 Due: 12/31/21

Effectiveness Study of CBT for Anxiety in Children

Phase: N/A Priority: Normal
NCT ID: NCT00586586 Org: User:
Start: 01/02/08 End: 03/21/14 Due: 03/21/15

Nasal Provocation Testing in Occupational Rhinitis

Phase: N/A Priority: Normal
NCT ID: NCT01436851 Org: User:
Start: 11/24/10 End: 12/31/14 Due: 12/31/15

Patient-reported Outcomes After Percutaneous Coronary Intervention

Phase: N/A Priority: Normal
NCT ID: NCT03810612 Org: User:
Start: 06/12/17 End: 05/31/30 Due: 05/31/31

The NADAPT Study: a Randomized Double-blind Trial of NAD Replenishment Therapy for Atypical Parkinsonism

Phase: N/A Priority: Normal
NCT ID: NCT06162013 Org: User:
Start: 03/05/24 End: 12/31/28 Due: 12/31/29

NOR-SYS: The Norwegian Stroke in the Young Study

Phase: N/A Priority: Normal
NCT ID: NCT01597453 Org: User:
Start: 09/01/10 End: 12/31/30 Due: 12/31/31

PAxlovid loNg cOvid-19 pRevention triAl With recruitMent In the Community in Norway

Phase: N/A Priority: Normal
NCT ID: NCT05852873 Org: User:
Start: 05/12/23 End: 04/30/26 Due: 04/30/27

Everolimus and Temozolomide in Advanced Gastroenteropancreatic Neuroendocrine Carcinoma (G3)

Phase: N/A Priority: Normal
NCT ID: NCT02248012 Org: User:
Start: 12/31/14 End: 12/01/19 Due: 12/01/20

Robotized Navigation Compared to Conventional Technique in Total Knee Replacement

Phase: N/A Priority: Normal
NCT ID: NCT04525950 Org: User:
Start: 09/07/20 End: 12/31/31 Due: 12/31/32

A Randomized Clinical Trial on Hemoglobin Dose and Patient Matching

Phase: N/A Priority: Normal
NCT ID: NCT01328262 Org: User:
Start: 11/30/10 End: 02/28/11 Due: 02/28/12

Allergic Transfusion Reactions in Plasma Transfusion

Phase: N/A Priority: Normal
NCT ID: NCT02200692 Org: User:
Start: 06/30/14 End: 03/31/18 Due: 03/31/19

Rehabilitation After Intensive Care

Phase: N/A Priority: Normal
NCT ID: NCT01770821 Org: User:
Start: 02/28/13 End: 12/31/16 Due: 12/31/17

NORVIT and WENBIT - Long-term Follow-up

Phase: N/A Priority: Normal
NCT ID: NCT00671346 Org: User:
Start: 12/31/98 End: 01/31/21 Due: 01/31/22